Boston Partners Haemonetics Corp Transaction History

Boston Partners

$80.6 Billion
Q3 2024

A detailed history of Boston Partners transactions in Haemonetics Corp stock. As of the latest transaction made, Boston Partners holds 420,756 shares of HAE stock, worth $29.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

420,756

Previous 425,006 1.0%

Holding current value

$29.8 Million

Previous $35.2 Million 3.82%

% of portfolio

0.04%

Previous 0.05%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$72.45 - $91.58 $307,912 - $389,215	-4,250 Reduced 1.0%	420,756 $33.8 Million
Q2 2024 Aug 13, 2024	SELL	$81.24 - $97.37 $1.56 Million - $1.87 Million	-19,174 Reduced 4.32%	425,006 $35.2 Million
Q1 2024 May 13, 2024	SELL	$71.24 - $85.35 $18.8 Million - $22.5 Million	-263,254 Reduced 37.21%	444,180 $37.9 Million
Q4 2023 Feb 07, 2024	SELL	$80.59 - $92.61 $1.95 Million - $2.24 Million	-24,168 Reduced 3.3%	707,434 $60.5 Million
Q3 2023 Nov 07, 2023	SELL	$82.56 - $93.49 $2.31 Million - $2.62 Million	-27,990 Reduced 3.68%	731,602 $65.5 Million
Q2 2023 Aug 10, 2023	BUY	$80.84 - $89.45 $7.75 Million - $8.58 Million	95,928 Added 14.45%	759,592 $64.7 Million
Q1 2023 May 09, 2023	BUY	$72.75 - $90.6 $10.7 Million - $13.4 Million	147,440 Added 28.56%	663,664 $54.9 Million
Q4 2022 Feb 07, 2023	BUY	$73.85 - $86.14 $16 Million - $18.6 Million	216,210 Added 72.07%	516,224 $40.6 Million
Q3 2022 Nov 09, 2022	SELL	$63.3 - $78.66 $570,079 - $708,411	-9,006 Reduced 2.91%	300,014 $22.6 Million
Q2 2022 Aug 10, 2022	BUY	$49.27 - $66.08 $270,738 - $363,109	5,495 Added 1.81%	309,020 $20.3 Million
Q1 2022 May 10, 2022	BUY	$43.77 - $63.22 $128,552 - $185,677	2,937 Added 0.98%	303,525 $19.1 Million
Q4 2021 Feb 04, 2022	SELL	$49.55 - $74.59 $228,970 - $344,680	-4,621 Reduced 1.51%	300,588 $15.9 Million
Q3 2021 Nov 05, 2021	SELL	$57.6 - $70.59 $130,924 - $160,451	-2,273 Reduced 0.74%	305,209 $21.5 Million
Q2 2021 Aug 12, 2021	BUY	$51.81 - $118.56 $15.9 Million - $36.5 Million	307,482 New	307,482 $20.4 Million
Q3 2018 Nov 14, 2018	SELL	$89.96 - $114.58 $1.8 Million - $2.29 Million	-20,005 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$71.53 - $95.75 $1.43 Million - $1.92 Million	20,005 New	20,005 $1.79 Million

Others Institutions Holding HAE

# of Institutions

330

Shares Held

53.9M

Call Options Held

689K

Put Options Held

345K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.63B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.

Account